Hummingbird Bioscience raises $125m in Ser...Danish Novo Holdings A/S has led an oversubscribed US$125m Series C into the cancer antibody specialist Hummingbird Bioscience. more ➔
BD installs production hub in ZaraogzaBD will build a €165m manufacturing facility in Zaragoza, Spain to support the growth of its pre-filled drug delivery business. more ➔
COVID-19 therapeutics: Germany launches ...German government has launched a €300m programme designed to bring clinically tested COVID-19 treatments to the patient’s bedside. more ➔
Recombinant silk producer AMSilk raises ...AMSilk GmbH has closed a Series C financing at €29m to accelerate and expand commercialisation of its microbially produced silk fibres. more ➔
SARS-CoV-2-antibodies may promote severe C...Immunoglobin G antibodies (IgG) produced in response to the SARS-CoV-2 spike protein appear to play a role in how COVID-19 can turn more severe in some cases. more ➔
Abingworth raises $582m for late-stage fun...International life sciences investment group Abingworth has closed a new clinical co-development fund at US$582m. more ➔
USA supports to temporarily waive IP of CO...The Biden administration has announced it will support the WHO proposal to temporarily waive intellectual property rights for COVID-19 vaccines to speed up vaccination. more ➔
Swiss Oculis SA raises $57m in Series CTopical ophthalmic therapies developer Oculis S.A. has closed a US$57m Series C financing to push development of its pipeline. more ➔
Mogrifiy completes Series A financing roun...Cell reprogramming specialist Mogrify Ltd has announced the second closing of its Series A financing of $17m, bringing the total raised to $33m in this round. more ➔
COVID-19 vaccine for poor countriesModerna Inc. has signed a COVID-19 vaccine supply agreement with vaccination alliance Gavi. more ➔